ArticleOncoimmunology2025

Divergent on-target off-tumor effects by CAR T and CAR NK cells suggest different efficacy and safety of cell therapies.

Katharina Schindler-Wnek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.